Donate Connect
SEARCH

FOP News

Regeneron Pharmaceuticals OPTIMA Trial Posted on ClinicalTrials.gov

Posted by · June 01, 2022 11:57 AM
Read more Share

Ipsen's Palovarotene Receives Regulatory Approval from Health Canada

Posted by · January 26, 2022 12:24 PM
Read more Share

Incyte Pharmaceuticals Has Submitted Their FOP Trial to ClinicalTrials.gov

Posted by · November 12, 2021 2:34 PM
Read more Share

An Additional Update for the FOP Community Regarding LUMINA-1 and Garetosmab

Posted by · October 01, 2021 10:59 AM
Read more Share

Two Ipsen Clinical Trials Released on ClinicalTrials.gov

Posted by · September 22, 2021 3:41 PM
Read more Share

Breaking News from Regeneron Regarding their FOP Clinical Program

Posted by · August 13, 2021 4:55 PM
Read more Share

Breaking News from Ipsen Regarding their US FDA Submission for Palovarotene

Posted by · August 13, 2021 9:10 AM
Read more Share

An Important Update from Regeneron Regarding the LUMINA-1 Trial

Posted by · June 04, 2021 10:32 AM
Read more Share

Palovarotene Regulatory Submission Accepted

Posted by · May 28, 2021 4:47 PM
Read more Share

FOP Brasil Takes on Newborn Screening

Posted by · May 20, 2021 12:21 PM
Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter